Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.

International journal of experimental pathology - 1 Jun 2022

Li Na, Xu Ling, Zhang Ji, Liu Yongyu

Abstract excerpt

Non-small cell lung cancer (NSCLC) is a malignant tumour with high mortality. FHL2 has been identified as a biomarker of lung cancer. This research explored the effects of FHL2 expression on NSCLC. NSCLC-associated data sets were collected from the assistant for clinical bioinformatics and TCGA databases respectively. The association between FHL2 and clinical characteristics, the prognostic significance of FHL2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherins
Share to Caspase 3
Share to Caspase 9

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Movement

Share to Epithelial-Mesenchymal Transition

Share to LIM-Homeodomain Proteins

Share to Mice, Nude

Share to Muscle Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 35366027
DOI: 10.1111/iep.12436
PMCID: PMC9107608

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.PMID 35366027Read ↗

MiR-96-5p Facilitates Lung Adenocarcinoma Cell Phenotypes by Inhibiting FHL1.Semantic proximity Read ↗

Shikonin triggers apoptosis in lung adenocarcinoma through FHL2-FOXO1 signaling axisSemantic proximity Read ↗

c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHITSemantic proximity Read ↗

KLF5 facilitates lung adenocarcinoma metastasis via regulating the epithelial-mesenchymal transition pathway through RHPN2Semantic proximity Read ↗

Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.Semantic proximity Read ↗

Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer.Semantic proximity Read ↗

Fibroblast Growth Factor 11 (FGF11) Promotes Non-small Cell Lung Cancer (NSCLC) Progression by Regulating Hypoxia Signaling PathwaySemantic proximity Read ↗

E3 ubiquitin ligase Pirh2 enhances tumorigenic properties of human non-small cell lung carcinoma cellsSemantic proximity Read ↗

KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.Semantic proximity Read ↗

FHL2 Regulates Cell Cycle-Dependent and Doxorubicin-Induced p21Cip1/Waf1 Expression in Breast Cancer CellsSemantic proximity Read ↗

Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.Semantic proximity Read ↗

Fibrillin 2 gene knockdown inhibits invasion and migration of lung cancer cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.